Condition
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06682494Not ApplicableRecruiting
Enhancing Oral Cancer Awareness
NCT07337122CompletedPrimary
Collagen Matrix in Oral Cancer Surgery
NCT07180901Not ApplicableRecruitingPrimary
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NCT06701058Completed
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
NCT06606301CompletedPrimary
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma
Showing all 5 trials